RecruitingNCT06788587
Longer-term stimulant treatment for methamphetamine use disorder
About this title
Read the official source — NCT06788587Medication studyAges 18–55CanadaAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- MontrealSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 18, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 80
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT06788587
- Official title
Show the full official title
Exploring Feasibility and Acceptability of Prolonged Administration of High-Dose Stimulants in People With Methamphetamine Use Disorder: An Extension of a Randomized, Placebo-Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre hospitalier de l'Université de Montréal (CHUM), a university.
Does this study involve medication?
Yes. The study involves medication, including LDX-01 plus TAU and Placebo plus TAU.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
